Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression. (Record no. 25861959)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02311 a2200661 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517085547.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201801s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1557-3265 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1158/1078-0432.CCR-15-2539 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Evageliou, Nicholas F |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180112 |
| 245 00 - TITLE STATEMENT | |
| Title | Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Clinical cancer research : an official journal of the American Association for Cancer Research |
| Date of publication, distribution, etc. | Sep 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 4391-404 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Celecoxib |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Transformation, Neoplastic |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Models, Animal |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Progression |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Evaluation, Preclinical |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Synergism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Eflornithine |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genes, myc |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Homeostasis |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, Transgenic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neuroblastoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Oncogene Proteins |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polyamines |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Haber, Michelle |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vu, Annette |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Laetsch, Theodore W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Murray, Jayne |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gamble, Laura D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cheng, Ngan Ching |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Kangning |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Reese, Megan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Corrigan, Kelly A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ziegler, David S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Webber, Hannah |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hayes, Candice S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pawel, Bruce |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Marshall, Glenn M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhao, Huaqing |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gilmour, Susan K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Norris, Murray D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hogarty, Michael D |
| 773 0# - HOST ITEM ENTRY | |
| Title | Clinical cancer research : an official journal of the American Association for Cancer Research |
| Related parts | vol. 22 |
| -- | no. 17 |
| -- | p. 4391-404 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1158/1078-0432.CCR-15-2539">https://doi.org/10.1158/1078-0432.CCR-15-2539</a> |
| Public note | Available from publisher's website |
No items available.